BIODESIX, INC.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2019 | $-21.7M | $-23.0M | $1.3M | $170.0K |
| FY2020 | $-21.4M | $-23.3M | $1.9M | $3.7M |
| FY2021 | $-28.2M | $-30.5M | $2.2M | $4.9M |
| FY2022 | $-45.0M | $-48.3M | $3.3M | $6.0M |
| FY2023 | $-22.9M | $-45.8M | $22.9M | $5.4M |
| FY2024 | $-48.6M | $-51.9M | $3.2M | $6.6M |
| FY2025 | $-23.3M | $-23.5M | $259.0K | $4.1M |